New eye drug shows promise for diabetes-related vision loss
NCT ID NCT07526857
First seen Apr 24, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This study tested the drug faricimab in 60 people with diabetic retinopathy, a diabetes complication that can damage eyesight. Researchers used special eye scans to see if the drug could reduce abnormal cells on blood vessels and restore protective yellow pigment in the macula. The goal was to track these changes over one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY (DR) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Naples, Federico II, Napoli, Napoli
Naples, Napoli, 80127, Italy
Conditions
Explore the condition pages connected to this study.